Bret Jensen

|RSS

Currently the editor of "The Biotech Forum," Bret Jensen was chief investment strategist for Simplified Asset Management (S.A.M.), a small long/short hedge fund based in Miami, from 2008-2011. The fund was in the top 5% of long/short hedge funds for total return in its first full year (2009), as ranked by Hedgeco fund database (more than 450 funds in category). Prior to this, he spent a decade as technology director of a Fortune 100 firm.Expand

Jensen has been a top-5%-ranked financial analyst and blogger since 2013, according to TipRanks. He holds a Bachelor of Science degree in finance from Arizona State University.

Follow Bret on Twitter: @Bret_Jensen.Collapse

By

Bret Jensen

 | Mar 6, 2017 | 11:30 AM EST
Companies developing drugs for cancer, eye problems and pets -- offer untapped value.
By

Bret Jensen

 | Mar 5, 2017 | 2:00 PM EST
I'm still enthusiastic about the sector, but it is critical to also be prudent.
By

Bret Jensen

 | Mar 3, 2017 | 1:00 PM EST
I'm still enthusiastic about the sector, but it is critical to also be prudent.
By

Bret Jensen

 | Mar 1, 2017 | 11:30 AM EST
Here's why to check out Dynavax Technologies as well Lexicon, Supernus and Acadia Pharmaceuticals.
By

Bret Jensen

 | Feb 27, 2017 | 12:55 PM EST
Delays in tax reform and infrastructure bills may lead to market 'hiccups' and lower entry points.
By

Bret Jensen

 | Feb 24, 2017 | 11:30 AM EST
Readers want to know what to do with the two biotech names, which are headed in opposite directions.
RMPIA
By

Bret Jensen

 | Feb 22, 2017 | 10:00 AM EST
These two large-cap drug giants should be core parts of any well-diversified portfolio.
RMPIA
By

Bret Jensen

 | Feb 20, 2017 | 10:00 AM EST
We explore whether the biotech rally can continue and if Gilead Sciences has bottomed.
RMPIA
By

Bret Jensen

 | Feb 17, 2017 | 1:00 PM EST
We explore whether the biotech rally can continue and if Gilead Sciences has bottomed.
RMPIA
By

Bret Jensen

 | Feb 15, 2017 | 11:30 AM EST
M&A activity is in a serious upswing, and here are some names to watch.

BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.